ALL insider plans sale of 33,614 shares via Goldman Sachs on NYSE
Rhea-AI Filing Summary
Form 144 notice for Allstate Corporation (ALL) reports a proposed sale of 33,614 shares of common stock through Goldman Sachs & Co. LLC on 10/06/2025 on the NYSE. The filing shows the shares were acquired as performance-award compensation on 02/17/2022 (18,989 shares), 02/18/2021 (11,536 shares) and 02/08/2019 (3,089 shares). The table lists an aggregate market value of $7,019,611.62 and a total outstanding share count of 263,505,334. No sales by the reporting person in the prior three months are reported. The filer certifies they are not aware of undisclosed material adverse information and includes the standard Rule 10b5-1/trading-plan notice language.
Positive
- Disclosure compliance—the filer provided a Form 144 with acquisition dates and amounts
- No prior sales reported in the last three months, indicating this is not part of a rapid sell-down
Negative
- Planned sale size of 33,614 shares equals an aggregate market value of $7,019,611.62, which could exert modest selling pressure around 10/06/2025
- Concentrated insider sale—all shares originate from performance awards granted between 2019 and 2022, reducing the holder's vested stake
Insights
This is a routine Form 144 notice for a planned insider sale of $7.02M in Allstate shares.
The filing documents a planned sale of 33,614 shares on 10/06/2025 via Goldman Sachs, with the securities originally received as performance-award compensation across 2019–2022. The seller attests to lacking undisclosed material information and references Rule 10b5-1 language.
Key dependencies include timely execution on the listed date and compliance with any adopted trading plan. Watch for an actual Form 4 reporting the completed sale shortly after the transaction date to confirm execution and final proceeds; absence of a Form 4 would be notable within days after 10/06/2025.